Dreavent’s Unique Fund Selection Process
At the heart of our investment process lies:
The Dreavent Engine
The Engine is our rigorous and proactive selection method for identifying top-tier biotech companies within the US ecosystem for investment. This process focuses on firms that are well-funded, have significant backing from large pharmaceutical companies and venture capitalists, and are developing technologies aligned with Dreavent's targeted healthcare areas. Our strategic approach aims to minimize investment risks by involving established and innovative entities in the biotech sector.
How “The Engine” Works
Twice a year, the Engine scans for US companies that are either venture-backed or growth-stage with prior venture capital or significant private investment.
Initial Scan
The first strategic filter narrows down the pool based on specific criteria related to the company's growth potential and alignment with our investment goals.
Strategic Filter 1
A second, more detailed filter further assesses the companies' fit with Dreavent's targeted healthcare areas and investment criteria.
Strategic Filter 2
Our team of experts conducts a thorough review of the pre-selected companies, analyzing factors such as financial stability, technological innovation, and strategic alignment.
Expert Review
The final step involves creating a refined and de-risked Master List companies that meet all our stringent investment criteria.
Master List Creation
A tool destined to stir up the analysis and selection of biotech companies.
The Dreavent Engine 2024 Target Fund aims to secure $125M in capital commitments.
For its inaugural cycle, the fund has shortlisted 12 high-conviction assets from an initial pool of 3,282, based on their potential for significant near to midterm data readouts.
Dreavent Engine 2024 strategically invests in top-tier biotech companies within the US, prioritizing those that are well-funded and supported by major pharmaceutical companies and venture capitalists. These firms focus on technologies that align with Dreavent's healthcare objectives.
This approach is designed to minimize investment risks by partnering with established and innovative players in the biotech industry.
<< Back to Strategy